Factors Influencing Delays in Patient Access to New Medicines in Canada: A Retrospective Study of Reimbursement Processes in Public Drug Plans

by Sam Salek, Sam Salek, Sarah Lussier Hoskyn, Jeffrey Roy Johns, Nicola Allen, Chander Sehgal
Published 2019-03-01

Cost-effectiveness of adding cetuximab to platinum-based chemotherapy for first-line treatment of recurrent or metastatic head and neck cancer.

by Malek B Hannouf, Chander Sehgal, Jeffrey Q Cao, Joseph D Mocanu, Eric Winquist, Gregory S Zaric
Published 2012-01-01

Pan-Canadian Pharmaceutical Alliance (pCPA): Timelines Analysis and Policy Implications

by Sam M. Salek, Sam M. Salek, Sarah Lussier Hoskyn, Jeffrey Johns, Nicola Allen, Chander Sehgal
Published 2019-02-01